CIS

Clinical Immunology Society (CIS)

2016 Annual Meeting: Immune Deficiency and Dysregulation North American Conference

Continuing Medical Education

2016 Annual Meeting

Purpose
Provide an opportunity for physicians to receive updated information and solidify their knowledge of primary immune deficiency.

Content Area
The content will cover practical, cutting edge and theoretical issues related to patient care. The majority of immune deficiencies will be covered to provide the maximal educational experience.

Target Audience
Physicians, scientists and nurses who are involved in the evaluation and/or care of patients with primary immune deficiencies. Participants should be pediatricians, internists, or scientists committed to the clinical management of patients with primary immunodeficiency diseases. These candidates may have backgrounds in immunology, adult medicine, rheumatology, hematology, laboratory immunology, or allergy/immunology.

Learning Objectives
At the completion of the activity participants should be able to:

  • Recognize the value of new research techniques;
  • Describe new research findings in immunology;
  • Explain the diagnosis and management of diseases and disorders across various subspecialties of medicine.

ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the Clinical Immunology Society (CIS). The CIS is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement
The Clinical Immunology Society designates this live activity for a maximum of 21.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

Update on Diagnostic Advances in PI

Purpose
The purpose is to provide an academic and educational forum for all clinicians and researchers from around the world to discuss diagnosis, diagnostic tools and pathogenesis of intrinsic genetic disorders of immunity and immune function

Target Audience
The target audience is clinical allergists/immunologists, clinical immunologists, rheumatologists, infectious disease specialists and hematologists who specifically focus in the care and treatment of patients with primary immunodeficiencies (PIDs). Additionally, the target audience includes clinical laboratory immunologists, other PhD level immunologists and scientists along with fellows in training in the above-mentioned clinical disciplines. 

Learning Objectives
At the completion of the activity participants should be able to:

  • Describe and apply appropriate test utilization strategies in the diagnostic work-up of patients with primary immunodeficiencies (PIDs)
  • Describe and interpret humoral immune responses in the context of PIDs
  • Describe, interpret and apply various flow cytometric, genetic and other tools for diagnosis and management of PIDs
  • Describe and apply laboratory testing and clinical interpretation of telomere testing for telomere and other bone marrow failure syndrome
  • Discuss and apply newer methods for radiation sensitivity testing

ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the Clinical Immunology Society (CIS). The CIS is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement
The Clinical Immunology Society designates this live activity for a maximum of 8 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.